January 15th 2025
How can personalized care, addressing comorbidities, and focusing on gradual improvement help increase treatment success for alcohol use disorder?
September 20th 2024
With MDMA on Hold, What’s Next for Psychedelics?
September 11th 2024The FDA instead issued a CRL for MDMA-assisted psychotherapy for PTSD, requesting an additional phase 3 trial to examine safety and efficacy. Other psychedelic compounds are proceeding with trials for psychiatric conditions. Learn more here.
Read More